Core Viewpoint - The company Haihong Jiyie is focused on the development and promotion of advanced medical devices, particularly in the field of optical imaging for medical diagnostics and surgical navigation, with significant innovations and market potential. Group 1: Company Overview - Haihong Jiyie Technology Development Company was established in 2012 and is located in Harbin, specializing in the research, production, sales, and export of medical diagnostic and surgical navigation devices [1] - The company has developed multiple leading technologies in the field of medical optical imaging, holding 42 intellectual property rights, including 18 invention patents and 19 software copyrights [1] - Haihong Jiyie has been recognized as a specialized and innovative small and medium-sized enterprise in Heilongjiang Province and has received the first prize for technological advancement in the province in 2024 [1] Group 2: Product Innovations - The laser lymphatic imaging device is the company's first product, designed to detect and treat lymphatic diseases, particularly lymphedema, which affects approximately 300 million patients globally [2] - The device provides clear dynamic imaging of the venous and lymphatic systems, allowing for precise evaluation and localization during surgeries, thus enhancing surgical visualization [2] - Other products include a surgical microscope with a magnification exceeding 50 times, a 4K fluorescence endoscope, and a microcirculation imaging neurophysiological diagnostic system, all of which are leading technologies in the domestic market [3] Group 3: Market Potential and Future Plans - The company anticipates significant profitability starting next year, with the surgical microscope alone projected to reach a market scale of 3.7 billion yuan by 2028 [3] - Haihong Jiyie is involved in a national key research project on diagnostic equipment and biomedical materials, enhancing its industry recognition and market competitiveness [3] - Future projects include integrating diagnostic machines with treatment robots to enable real-time transmission of detected issues for autonomous surgical interventions, advancing intelligent medical technology [4]